GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1,543 Cr | ₹-524 Cr | ₹-696 Cr | ₹-428 Cr | ₹-358 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-1,543 Cr |
Mar2022 | ₹-524 Cr |
Mar2021 | ₹-696 Cr |
Mar2020 | ₹-428 Cr |
Mar2019 | ₹-358 Cr |
How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-1,543 Cr | Negative | |
Mar2022 | ₹-524 Cr | Negative | |
Mar2021 | ₹-696 Cr | Negative | |
Mar2020 | ₹-428 Cr | Negative | |
Mar2019 | ₹-358 Cr | - |
Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹36,128.8 Cr | 9.5% | 8.6% | 64.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 9.5% |
8.6% |
64.8% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses